Back to Network
10
Shared Docs
10
Same-Page
10 / 10
Mentions
Document Mentions (10 shared documents)
2 mentions1 same-page
Page ?Same page
ts on fixed income, mandatory converts Jeffrey, Rich mentioned you're interested in potentially buying
TEVA's positioning In generic pharma where scale and product diversity are increasingly important. TWA remains one of our top picks In Spec Pharma. Frontier Comm (FTR) - BAML reaffirming BUY after Frontier reported its first post-Verizon assets merger results. FTR's earnings miss was due to a decline in the le
2 mentions1 same-page
Page ?Same page
gc015.jpg: image016.jpg: image017.jpg Jeffrey, Rich mentioned you're interested in potentially buying
TEVA's positioning in generic pharma where scale and product diversity are increasingly important. TWA remains one of our top picks in Spec Pharma. Frontier Comm (FTR) - BAM reaffirming BUY after rontier reported its first post-Verizon assets merger results. FTR's ea nings miss was due to a decline in the lega
2 mentions1 same-page
Page ?Same page
fixed income, mandatory converts Jeffrey, =/u> Rich mentioned you're=interested in potentially buying
EVA's positioning in generic pharma where scale and pro=uct diversity are increasingly important. TEVA remains one of our top pick= in Spec Pharma. Frontier Comm (FTR) - BAM= reaffirming BUY after Frontier reported its first post-Verizon assets merger results. =TR's earnings miss was due to a decline in the l
Sponsored
2 mentions1 same-page
Page ?Same page
ts on fixed income, mandatory converts Jeffre=, Rich m=ntioned you're interested in potentially buying
ositioning in generic=pharma where scale and product diversity are increasingly important. TEVA =emains one of our top picks in Spec Pharma.<=span> Frontier Comm (FTR) - BAML reaffirming BUY after Frontier reported its first post-Verizon assets merger results. FTR's earnings miss was due to a=decline in the l
2 mentions1 same-page
Page ?Same page
fixed income, mandatory converts Jeffrey, =/u> Rich mentioned you're=interested in potentially buying
EVA's positioning in generic pharma where scale and pro=uct diversity are increasingly important. TEVA remains one of our top pick= in Spec Pharma. Frontier Comm (FTR) - BAM= reaffirming BUY after Frontier reported its first post-Verizon assets merger results. =TR's earnings miss was due to a decline in the l
2 mentions1 same-page
Page ?Same page
ts on fixed income, mandatory converts Jeffrey, Rich mentioned you're interested in potentially buying
EVA's positioning in generic pharma where scale and product diversity are increasingly important. TEVA remains one of our top picks in Spec Pharma. Frontier Comm (FIR) - BAML reaffirming BUY after Frontier reported its first post-Verizon assets merger results. FTR's earnings miss was due to a decline in the l
Sponsored
2 mentions1 same-page
Page ?Same page
ts on fixed income, mandatory converts Jeffrey, Rich mentioned you're interested in potentially buying
EVA's positioning in generic pharma where scale and product diversity are increasingly important. TEVA remains one of our top picks in Spec Pharma. Frontier Comm (FTR) - BAML reaffirming BUY after Frontier reported its first post-Verizon assets merger results. FTR's earnings miss was due to a decline in the l
2 mentions1 same-page
Page ?Same page
ts on fixed income, mandatory converts Jeffrey, Rich mentioned you're interested in potentially buying
EVA's positioning in generic pharma where scale and product diversity are increasingly important. TEVA remains one of our top picks in Spec Pharma. Frontier Comm (FTR) - BAML reaffirming BUY after Frontier reported its first post-Verizon assets merger results. FTR's earnings miss was due to a decline in the l
2 mentions1 same-page
Page ?Same page
fixed income, mandatory converts Jeffrey, =/u> Rich mentioned you're=interested in potentially buying
EVA's positioning in generic pharma where scale and pro=uct diversity are increasingly important. TEVA remains one of our top pick= in Spec Pharma. Frontier Comm (FTR) - BAM= reaffirming BUY after Frontier reported its first post-Verizon assets merger results. =TR's earnings miss was due to a decline in the l
Sponsored
2 mentions1 same-page
Page ?Same page
ts on fixed income, mandatory converts Jeffrey, Rich mentioned you're interested in potentially buying
EVA's positioning in generic pharma where scale and product diversity are increasingly important. TEVA remains one of our top picks in Spec Pharma. Frontier Comm (FTR) - BAML reaffirming BUY after Frontier reported its first post-Verizon assets merger results. FTR's earnings miss was due to a decline in the l
Sponsored
Mutual Connections (32)
Entities connected to both Marc Rich and Frontier Comm
Jeffrey Epstein
PERSON22,722 w/ Marc·10 w/ Frontier
Richard Kahn
PERSON19,040 w/ Marc·10 w/ Frontier
Bloomberg L.P.
ORGANIZATION320 w/ Marc·10 w/ Frontier
AM
Amanda
PERSON224 w/ Marc·7 w/ Frontier
Bank of America
ORGANIZATION66 w/ Marc·4 w/ Frontier
Pierce, Fenner & Smith Incorporated
ORGANIZATION48 w/ Marc·4 w/ Frontier
Paul Volcker
PERSON41 w/ Marc·10 w/ Frontier
AE
Amanda Ens
PERSON44 w/ Marc·6 w/ Frontier
Frontier Communications
ORGANIZATION29 w/ Marc·10 w/ Frontier
HM
Hans Mikkelsen
PERSON12 w/ Marc·10 w/ Frontier
US Treasury ETF
ORGANIZATION11 w/ Marc·10 w/ Frontier
Spec Pharma
ORGANIZATION12 w/ Marc·9 w/ Frontier
Teva Pharma
ORGANIZATION11 w/ Marc·10 w/ Frontier
Chart One
ORGANIZATION11 w/ Marc·10 w/ Frontier
S&P500 ETF
ORGANIZATION11 w/ Marc·10 w/ Frontier
Investment Grade Supply
ORGANIZATION11 w/ Marc·10 w/ Frontier
Investment Grade ETF
ORGANIZATION11 w/ Marc·10 w/ Frontier
Outlook
ORGANIZATION13 w/ Marc·6 w/ Frontier
Allergan
LOCATION9 w/ Marc·9 w/ Frontier
PR
Pfd Return
PERSON7 w/ Marc·7 w/ Frontier